We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?
Oliver J. Lindhiem, PhD
Advertisement
Dr Lindhiem is an associate professor of psychiatry at the University of Pittsburgh.
Articles by Oliver J. Lindhiem, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
2
Treating Mental Illness During Pregnancy the Same as Any Medical Illness: In Conversation With Jennifer L. Payne, MD
3
Exploring CBT Approaches for Chronic Insomnia in Adults: A Systematic Review and Network Meta-Analysis
4
The Use of Aripiprazole for Bipolar Disorder
5
